Moderna's share (MRNA) price has been running in a narrow price range since November 8 after a series of gains extending since October 21, surpassing the short and long-term exponential moving averages in a positive short-term sign. Meanwhile, an unclear zigzag path has dominated MRNA share since the beginning of the year.
As for now, and on the daily chart, we keep an eye on 180.13 and $198.82 as possible bullish targets, as we await the bullish crossover of the MA-25 and MA-50 to achieve the possible bullish path.
On the flip side, if MRNA share price fails to stabilize above the $162 level, the previous bullish hypothesis may be invalidated, and we may witness a pullback towards $142-135 levels (yellow shaded area).
As for now, and on the daily chart, we keep an eye on 180.13 and $198.82 as possible bullish targets, as we await the bullish crossover of the MA-25 and MA-50 to achieve the possible bullish path.
On the flip side, if MRNA share price fails to stabilize above the $162 level, the previous bullish hypothesis may be invalidated, and we may witness a pullback towards $142-135 levels (yellow shaded area).
Trade closed: target reached
Trade active:
MRNA may test the support of 162 level again soon. Also, keep an eye on 180.13 level.